Inventor · disambiguated record
Francois-Xavier Mahon
Also filed as: MAHON FRANCOIS-XAVIER
1 granted patent·11 pending applications·10 citations·filing 2002–2016
33Inventor score
Top patents by PatentIndex Score
12 records- 0168US6987103B2Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agentsSTRAGEN PHARMA S A·Filed 2003·Granted Jan 17, 2006·10 cites·25 claims
- 0260US2010021921A1Mutated abl kinase domainsBARTHE CHRISTOPHE·Filed 2009·Application pending·0 cites
- 0360US2010021920A1Mutated abl kinase domainsBARTHE CHRISTOPHE·Filed 2009·Application pending·0 cites
- 0452US2009191606A1Organic compoundsBARTHE CHRISTOPHE·Filed 2008·Application pending·0 cites
- 0551US2005202519A1Mutated abl kinase domainsFiled 2002·Application pending·0 cites
- 0649US2009281113A1Method of optimizing the treatment of philadelphia-positive leukemia with abl tyrosine kinase inhibitorsNOVARTIS AG·Filed 2007·Application pending·0 cites
- 0747US2011129852A1Organic compoundsBARTHE CHRISTOPHE·Filed 2010·Application pending·0 cites
- 0846US2006148058A1Organic compoundsBARTHE CHRISTOPHE·Filed 2006·Application pending·0 cites
- 0941US2003170851A1Organic compoundsFiled 2002·Application pending·0 cites
- 1036US2017007605A1Method of Optimizing the Treatment of Philadelphia-positive Leukemia with Abl Tyrosine Kinase InhibitorsGATHMANN INSA·Filed 2016·Application pending·0 cites
- 1133US2011190220A1Use of Defensin Alpha 1 and/or Defensin Alpha 4, as a Marker for Predicting Treatment Response and/or a Relapse in a Patient Suffering form Chronic Myeloid LeukemiaTURCQ BEATRICE·Filed 2009·Application pending·0 cites
- 1224US2005049268A1Use of at least one abl, kit and/or platelet-derived growth factor receptor tyrosine kinases inhibitor for treating hair depigmentationFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Francois-Xavier Mahon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →